Evidence map›Paper›PMID 36764290›Full record

ArticleCell2023

Cryo-EM structure of the RADAR supramolecular anti-phage defense complex.

Brianna Duncan-Lowey, Nitzan Tal, Alex G Johnson, Shaun Rawson, Megan L Mayer, Shany Doron, Adi Millman, Sarah Melamed, Taya Fedorenko, Assaf Kacen and 5 more

Abstract read
In one paragraph

Article in Cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genomic analysis of prophages in 44 clinical strains ofFrontiers in cellular and infection microbiology · 2025
    Article
  18. Article
  19. Overview of Phage Defense Systems in Bacteria and Their Applications.International journal of molecular sciences · 2024
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Brianna Duncan-LoweyDepartment of Microbiology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Nitzan TalDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Alex G JohnsonDepartment of Microbiology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Shaun RawsonHarvard Center for Cryo-Electron Microscopy, Harvard Medical School, Boston, MA 02115, USA.
Megan L MayerHarvard Center for Cryo-Electron Microscopy, Harvard Medical School, Boston, MA 02115, USA.
Shany DoronDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Adi MillmanDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Sarah MelamedDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Taya FedorenkoDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Assaf KacenDepartment of Immunology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Alexander BrandisLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Tevie MehlmanLife Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Gil AmitaiDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Rotem SorekDepartment of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. Electronic address: rotem.sorek@weizmann.ac.il.
Philip J KranzuschDepartment of Microbiology, Harvard Medical School, Boston, MA 02115, USA; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Parker Institute for Cancer Immunotherapy at Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: philip_kranzusch@dfci.harvard.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RADAR is a two-protein bacterial defense system that was reported to defend against phage by "editing" messenger RNA. Here, we determine cryo-EM structures of the RADAR defense complex, revealing RdrA as a heptameric, two-layered AAA+ ATPase and RdrB as a dodecameric, hollow complex with twelve surface-exposed deaminase active sites. RdrA and RdrB join to form a giant assembly up to 10 MDa, with RdrA docked as a funnel over the RdrB active site. Surprisingly, our structures reveal an RdrB active site that targets mononucleotides. We show that RdrB catalyzes ATP-to-ITP conversion in vitro and induces the massive accumulation of inosine mononucleotides during phage infection in vivo, limiting phage replication. Our results define ATP mononucleotide deamination as a determinant of RADAR immunity and reveal supramolecular assembly of a nucleotide-modifying machine as a mechanism of anti-phage defense.

Indexed as

BacteriophagesAdenosine DeaminaseAdenosine TriphosphateATPases Associated with Diverse Cellular ActivitiesCryoelectron MicroscopyAdenosine DeaminaseAdenosine TriphosphateATPases Associated with Diverse Cellular Activitiesadenosine deaminaseanti-phage immunityphage

Identifiers

PMID36764290
PMCPMC9994260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.